OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

McCormick & Co Inc/  US5797802064  /

IEX
2024-08-30  9:59:59 PM Chg. +0.99 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
80.03USD +1.25% 61,704
Turnover: 4.93 mill.		 -Bid Size: - -Ask Size: - 21.5 bill.USD 1.95% 31.51
GlobeNewswire 08-20 Rendering Speculation Unnecessary, TrustCo Delivers Again With a Quarterly Dividend of $0.36 Per Sha...
GlobeNewswire 08-20 Lone Star PACE Facilitates $27M in Retroactive C-PACE Financing for Luxury Hotel in Dallas Arts Dist...
GlobeNewswire 08-05 H&R Block Names Tiffany Mason as Next Chief Financial Officer
GlobeNewswire 07-31 Package with Paper or Poly on PAC Machinery’s new Rollbag® R3200 Fulfillment Paper Auto Bagger
GlobeNewswire 07-22 TrustCo Delivers Once Again With Second Quarter Results Net Interest Margin Up 3.7% on Loan Growth o...
GlobeNewswire 07-19 Significant Donation Helped USO Expand Its Impact in Europe
GlobeNewswire 07-18 Lone Star PACE Hires Tenured Communications Strategist to Lead Marketing Efforts
GlobeNewswire 07-16 Trustco Bank Announces Management Changes – Leonard, Curley, and Others Assume New Roles
GlobeNewswire 07-09 Aqualab Lead Food Scientist, Zachary Cartwright, PhD, Takes Leadership Role at IFT First Annual Even...
GlobeNewswire 06-25 Ingersoll Rand Names Scott Watson as Leader for Life Science Technologies Platform
GlobeNewswire 06-24 LGI Homes Opens First Community in Baltimore
GlobeNewswire 06-21 MEDIA ALERT: Paylocity Champions Mental Health with NAMI at SHRM24
GlobeNewswire 06-10 SPX Technologies Announces Appointment of Cherée Johnson as Chief Legal Officer
GlobeNewswire 06-07 NIRI Twin Cities Chapter Elects 2024-2025 Board of Directors
GlobeNewswire 06-06 Dozens of @properties Christie’s International Real Estate Agents Named to Prestigious 2024 RealTren...
GlobeNewswire 06-03 BriaCell Presents Clinical Efficacy Data at ASCO 2024
GlobeNewswire 06-03 Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire 06-02 Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire 06-01 Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
GlobeNewswire 06-01 Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
GlobeNewswire 05-30 Ispire Technology Inc. to Present at the KCSA Cannabis Virtual Investor Conference June 5th
GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 05-30 Expanding retirement security for Ontario’s healthcare workers: HOOPP welcomes 35 new employers to t...
GlobeNewswire 05-30 ImCheck to Present Promising ICT01 Data from the EVICTION Study at ASCO 2024
GlobeNewswire 05-29 Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Ph...